drugset / Trial / NCT03775993

Treatment of GHD Associated With CHF

NCT03775993

Phase 3 Unknown 64 enrolled Federico II University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Aim of the current study is to assess the cardiovascular effects of GH replacement therapy in patients with coexisting GHD and CHF

Timeline

Start
2019-03-01
Primary completion
2022-03-01
Completion
2022-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Somatropin Protein / enzyme biologic 0.012 mg/kg